Grafting of 2-Hydroxypropyl-β-Cyclodextrin on Gum Arabic-Modified Iron Oxide Nanoparticles as a Magnetic Carrier for Targeted Delivery of Hydrophobic Anticancer Drug
Article first published online: 11 DEC 2008
© 2008 The American Ceramic Society
International Journal of Applied Ceramic Technology
Volume 7, Issue 1, pages 111–118, January/February 2010
How to Cite
Banerjee, S. S. and Chen, D.-H. (2010), Grafting of 2-Hydroxypropyl-β-Cyclodextrin on Gum Arabic-Modified Iron Oxide Nanoparticles as a Magnetic Carrier for Targeted Delivery of Hydrophobic Anticancer Drug. International Journal of Applied Ceramic Technology, 7: 111–118. doi: 10.1111/j.1744-7402.2008.02332.x
This work was supported by the Landmark Project of National Cheng Kung University, Taiwan. We are also grateful to the National Science Council (contract no. NSC 95-2221-E006-406-MY2) of the Republic of China for the support of this research.
- Issue published online: 4 JAN 2010
- Article first published online: 11 DEC 2008
A new magnetic nanocarrier for the targeted delivery of hydrophobic drugs was developed by modifying magnetic nanoparticles with gum arabic and grafting with 2-hydroxypropyl-cyclodextrins (HCD) using hexamethylene diisocyanate (HMDI) as a linker. The size, hydrodynamic diameter, and grafting of HCD were characterized. The resultant magnetic nanocarrier exhibited an excellent capability to load all-trans-retinoic acid (ATRA), an anticancer agent. The better biocompatibility and the combined properties of specific targeting and complexation ability with hydrophobic drugs make the nanosystem an exciting prospect for targeted delivery of hydrophobic drugs.